Lenz Therapeutics, Inc. (LENZ) — DEF 14A Filings
All DEF 14A filings from Lenz Therapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
LENZ Therapeutics Files 2025 Proxy Statement
— Apr 28, 2025 Risk: low
LENZ Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 10, 2025. The company, formerly known a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX